• Ex-Takeda VP Tauhid Ali, Ph.D., with broad leadership and drug development experience becomes Board Director
• Seasoned regulatory strategist Darren Rubin becomes VP, Amalive, heading development of the ammonia scavenger OPA, Yaqrit’s phase 3 treatment for hepatic encephalopathy
• Ex-J&J senior medtech director Sarah van Hellenberg Hubar-Fisher joins as VP Business Development leading commercial development of Yaqrit’s medical device assets
February 21, 2025
